ClinVar Miner

Submissions for variant NM_000536.4(RAG2):c.293del (p.Thr98fs)

dbSNP: rs1851096223
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 1
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Invitae RCV001041863 SCV001205509 pathogenic Combined immunodeficiency with skin granulomas; Severe combined immunodeficiency, autosomal recessive, T cell-negative, B cell-negative, NK cell-positive 2019-11-20 criteria provided, single submitter clinical testing This sequence change results in a premature translational stop signal in the RAG2 gene (p.Thr98Asnfs*33). While this is not anticipated to result in nonsense mediated decay, it is expected to disrupt the last 429 amino acids of the RAG2 protein. This variant is not present in population databases (ExAC no frequency). For these reasons, this variant has been classified as Pathogenic. This deletion results in the loss of more than 60% of the protein and affects important functional domains for enzymatic activity and histone interaction (PMID: 16111638, 18033247, 25707801, 26692406). Furthermore, many variants in this region have been reported to be deleterious (PMID: 11133745, 16960852). This variant has not been reported in the literature in individuals with RAG2-related conditions.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.